BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Apr 21, 2005
Insider Transaction Report
Form 4
BELL STEVEN J
VP Research & Pre-Clinical Dev
Transactions
- Sale
Common Stock
2005-04-13$4.10/sh−100$410→ 4,375 total - Sale
Common Stock
2005-04-20$4.00/sh−1,600$6,400→ 2,775 total - Sale
Common Stock
2005-04-21$4.00/sh−500$2,000→ 2,275 total - Sale
Common Stock
2005-04-12$4.14/sh−500$2,068→ 4,475 total